Evidence map

ArticleHeliyon2024

Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer.

Hsiu-Chuan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38560690